{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:10:04Z","timestamp":1794622204079,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10549-014-3137-x","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T11:20:16Z","timestamp":1411557616000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients"],"prefix":"10.1007","volume":"148","author":[{"given":"So-Youn","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seeyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Sung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmee","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Hae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsil","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"issue":"1","key":"3137_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","volume":"17","author":"TF Hack","year":"1999","unstructured":"Hack TF, Cohen L, Katz J (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1):143\u2013149","journal-title":"J Clin Oncol"},{"issue":"20","key":"3137_CR2","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1200\/JCO.2002.09.018","volume":"20","author":"W Kwan","year":"2002","unstructured":"Kwan W, Jackson J, Weir LM (2002) Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20(20):4242\u20134248","journal-title":"J Clin Oncol"},{"issue":"6","key":"3137_CR3","first-page":"506","volume":"19","author":"R Gartner","year":"2010","unstructured":"Gartner R, Jensen MB, Kronborg L (2010) Self-reported arm-lymphedema and functional impairment after breast cancer treatment\u2013a nationwide study of prevalence and associated factors. Breast 2010 19(6):506\u2013515","journal-title":"Breast 2010"},{"issue":"6","key":"3137_CR4","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","volume":"92","author":"JA Petrek","year":"2001","unstructured":"Petrek JA, Senie RT, Peters M, Rosen pp (2001) Lymphedema in a cohort of breast carcinoma survivors 20\u00a0years after diagnosis. Cancer 92(6):1368\u20131377","journal-title":"Cancer"},{"issue":"2","key":"3137_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10549-008-9940-5","volume":"113","author":"KA Meeske","year":"2009","unstructured":"Meeske KA, Sullivan-Halley J, Smith AW et al (2009) Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 113(2):383\u2013391","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3137_CR6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515","journal-title":"Lancet Oncol"},{"issue":"3","key":"3137_CR7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","volume":"86","author":"M Kim","year":"2013","unstructured":"Kim M, Kim SW, Lee SU et al (2013) A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys 86(3):498\u2013503","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"3137_CR8","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1245\/s10434-012-2828-y","volume":"20","author":"MC Specht","year":"2013","unstructured":"Specht MC, Miller CL, Skolny MN et al (2013) Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients. Ann Surg Oncol 20(9):2835\u20132841","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"3137_CR9","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1245\/s10434-013-3408-5","volume":"21","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, Hoskin TL, Cheville AL et al (2014) Risk factors associated with breast lymphedema. Ann Surg Oncol 21(4):1202\u20131208","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3137_CR10","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00520-013-1770-2","volume":"21","author":"SL Kilbreath","year":"2013","unstructured":"Kilbreath SL, Lee MJ, Refshauge KM et al (2013) Transient swelling versus lymphoedema in the first year following surgery for breast cancer. Support Care Cancer 21(8):2207\u20132215","journal-title":"Support Care Cancer"},{"issue":"11","key":"3137_CR11","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-1245","volume":"19","author":"SA Norman","year":"2010","unstructured":"Norman SA, Localio AR, Kallan MJ et al (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19(11):2734\u20132746","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"3137_CR12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1158\/1055-9965.EPI-06-0168","volume":"16","author":"ED Paskett","year":"2007","unstructured":"Paskett ED, Naughton MJ, McCoy TP et al (2007) The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 16(4):775\u2013782","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"3137_CR13","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007\u20132014","journal-title":"J Clin Oncol"},{"issue":"1","key":"3137_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-014-2856-3","volume":"144","author":"CL Miller","year":"2014","unstructured":"Miller CL, Specht MC, Skolny MN et al (2014) Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat 144(1):71\u201377","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3137_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","volume":"88","author":"LE Warren","year":"2014","unstructured":"Warren LE, Miller CL, Horick N et al (2014) The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys 88(3):565\u2013571","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3137_CR16","doi-asserted-by":"crossref","first-page":"e26946","DOI":"10.1371\/journal.pone.0026946","volume":"6","author":"YY Qin","year":"2011","unstructured":"Qin YY, Li H, Guo XJ et al (2011) Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PLoS ONE 6(11):e26946","journal-title":"PLoS ONE"},{"issue":"2","key":"3137_CR17","doi-asserted-by":"crossref","first-page":"H963","DOI":"10.1152\/ajpheart.01052.2003","volume":"287","author":"A Bronstad","year":"2004","unstructured":"Bronstad A, Berg A, Reed RK (2004) Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure. Am J Physiol Heart Circ Physiol 287(2):H963\u2013H968","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"34","key":"3137_CR18","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","volume":"24","author":"SE Jones","year":"2006","unstructured":"Jones SE, Savin MA, Holmes FA et al (2006) Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 24(34):5381\u20135387","journal-title":"J Clin Oncol"},{"issue":"3","key":"3137_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.2010.30.8213","volume":"29","author":"M Andersson","year":"2011","unstructured":"Andersson M, Lidbrink E, Bjerre K et al (2011) Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study. J Clin Oncol 29(3):264\u2013271","journal-title":"J Clin Oncol"},{"issue":"1","key":"3137_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11764-012-0251-9","volume":"7","author":"SA Dominick","year":"2013","unstructured":"Dominick SA, Madlensky L, Natarajan L, Pierce JP (2013) Risk factors associated with breast cancer-related lymphedema in the WHEL Study. J Cancer Surviv 7(1):115\u2013123","journal-title":"J Cancer Surviv"},{"issue":"3","key":"3137_CR21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10549-011-1667-z","volume":"130","author":"RL Ahmed","year":"2011","unstructured":"Ahmed RL, Schmitz KH, Prizment AE, Folsom AR (2011) Risk factors for lymphedema in breast cancer survivors, the Iowa Women\u2019s Health Study. Breast Cancer Res Treat 130(3):981\u2013991","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3137_CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/bjs.9401","volume":"101","author":"H Sackey","year":"2014","unstructured":"Sackey H, Magnuson A, Sandelin K et al (2014) Arm lymphoedema after axillary surgery in women with invasive breast cancer. Br J Surg 101(4):390\u2013397","journal-title":"Br J Surg"},{"issue":"1","key":"3137_CR23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.sla.0000259390.51203.7b","volume":"246","author":"AD Purushotham","year":"2007","unstructured":"Purushotham AD, Bennett Britton TM, Klevesath MB et al (2007) Lymph node status and breast cancer-related lymphedema. Ann Surg 246(1):42\u201345","journal-title":"Ann Surg"},{"issue":"5","key":"3137_CR24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0360-3016(02)04273-6","volume":"55","author":"JJ Coen","year":"2003","unstructured":"Coen JJ, Taghian AG, Kachnic LA et al (2003) Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55(5):1209\u20131215","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3137-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3137-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3137-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T06:04:52Z","timestamp":1565849092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3137-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["3137"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3137-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]}}}